Unicorn Capital Partners
独秀资本
Unicorn Capital Partners (独秀资本) is a China-focused venture capital firm. In the available material, it appears as a participant in two disclosed deals: it led the B+ round for domestic cloud-based UI design tool Js.Design , and it joined a follow-on investment in Ze'an Biopharmaceutical alongside Lanchi Ventures, 5Y Capital, and others . elsewheres corpus does not contain a dedicated profile of the firm covering its founding date, fund size, or full investment strategy.
AI-generated — may contain errors, please verify.
Coverage
BlueRun Ventures Portfolio Company NeoImmuneTech Completes $38 Million Financing to Advance First-in-Class "Myeloid Cell Engager" Immunotherapy Pipeline | BlueRun Family
From Technical Platform Validation to Clinical Value
Zean completes $40 million Series A+ round to accelerate development of myeloid cell engager pipeline | BlueRun Ventures Family
Focusing on unmet clinical needs in major disease areas such as cancer and autoimmune diseases.
From PhD to "Foreman": Building a Robot Bricklayer, Paid for by Middle Eastern Tycoons | Linear Capital Portfolio Company
One robot replaces ten skilled workers, with efficiency up 14-fold
Code Moment | Js.Design Announces Tens of Millions of Dollars in Series B+ Funding, Existing Shareholder Source Code Capital Follows On
Co-defining China's design tools with Chinese designers
